Alpha-Synuclein and Mitochondrial Dysfunction in Parkinson's Disease: The Emerging Role of VDAC

被引:45
|
作者
Risiglione, Pierpaolo [1 ]
Zinghirino, Federica [1 ]
Di Rosa, Maria Carmela [1 ]
Magri, Andrea [2 ,3 ]
Messina, Angela [2 ,3 ]
机构
[1] Univ Catania, Dept Biomed & Biotechnol Sci, Via Santa Sofia 64, I-95125 Catania, Italy
[2] Univ Catania, Dept Biol Geol & Environm Sci, Via Santa Sofia 64, I-95125 Catania, Italy
[3] WeMitoBiotech SRL, C So Italia 172, I-95125 Catania, Italy
关键词
Alpha-Synuclein; mitochondria; VDAC; Parkinson's disease; mitochondrial dysfunction; DEPENDENT ANION CHANNEL; PERMEABILITY TRANSITION PORE; BCL-2 FAMILY PROTEINS; COMPLEX-I DEFICIENCY; OXIDATIVE STRESS; HEXOKINASE-I; CYTOCHROME-C; ENDOPLASMIC-RETICULUM; SUPEROXIDE-PRODUCTION; OLIGOMERS INTERACT;
D O I
10.3390/biom11050718
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Alpha-Synuclein (alpha Syn) is a protein whose function is still debated, as well as its role in modulation of mitochondrial function in both physiological and pathological conditions. Mitochondrial porins or Voltage-Dependent Anion Channel (VDAC) proteins are the main gates for ADP/ATP and various substrates towards the organelle. Furthermore, they act as a mitochondrial hub for many cytosolic proteins, including alpha Syn. This review analyzes the main aspects of alpha Syn-mitochondria interaction, focusing on the role of VDAC and its emerging involvement in the pathological processes.
引用
收藏
页数:19
相关论文
共 50 条
  • [21] Membrane Interactions of Oligomeric Alpha-Synuclein: Potential Role in Parkinson's Disease
    van Rooijen, Bart D.
    Claessens, Mireille M. A. E.
    Subramaniam, Vinod
    CURRENT PROTEIN & PEPTIDE SCIENCE, 2010, 11 (05) : 334 - 342
  • [22] Alpha-synuclein, Proteotoxicity and Parkinson's Disease: Search for Neuroprotective Therapy
    Ganguly, Upasana
    Chakrabarti, Sankha Shubhra
    Kaur, Upinder
    Mukherjee, Anwesha
    Chakrabarti, Sasanka
    CURRENT NEUROPHARMACOLOGY, 2018, 16 (07) : 1086 - 1097
  • [23] Alpha-Synuclein as a Biomarker for Parkinson's Disease
    Atik, Anzari
    Stewart, Tessandra
    Zhang, Jing
    BRAIN PATHOLOGY, 2016, 26 (03) : 410 - 418
  • [24] The genetic architecture of mitochondrial dysfunction in Parkinson's disease
    Larsen, S. B.
    Hanss, Z.
    Krueger, R.
    CELL AND TISSUE RESEARCH, 2018, 373 (01) : 21 - 37
  • [25] Alpha-Synuclein and Familial Parkinson's Disease
    Pankratz, Nathan
    Nichols, William C.
    Elsaesser, Veronika E.
    Pauciulo, Michael W.
    Marek, Diane K.
    Halter, Cheryl A.
    Wojcieszek, Joanne
    Rudolph, Alice
    Pfeiffer, Ronald F.
    Foroud, Tatiana
    MOVEMENT DISORDERS, 2009, 24 (08) : 1125 - 1131
  • [26] Alpha-Synuclein Nitration and Its Implications in Parkinson's Disease
    He, Yixi
    Yu, Zhongwang
    Chen, Shengdi
    ACS CHEMICAL NEUROSCIENCE, 2019, 10 (02): : 777 - +
  • [27] Emerging urinary alpha-synuclein and miRNA biomarkers in Parkinson’s disease
    Banabihari Giri
    Marissa Seamon
    Aditi Banerjee
    Sneha Chauhan
    Sharad Purohit
    John Morgan
    Babak Baban
    Chandramohan Wakade
    Metabolic Brain Disease, 2022, 37 : 1687 - 1696
  • [28] Mitochondrial Dysfunction: The Road to Alpha-Synuclein Oligomerization in PD
    Esteves, A. R.
    Arduino, D. M.
    Silva, D. F. F.
    Oliveira, C. R.
    Cardoso, S. M.
    PARKINSONS DISEASE, 2011, 2011
  • [29] Common Mechanisms Underlying a-Synuclein-Induced Mitochondrial Dysfunction in Parkinson's Disease
    Sohrabi, Tahereh
    Mirzaei-Behbahani, Behnaz
    Zadali, Ramin
    Pirhaghi, Mitra
    Morozova-Roche, Ludmilla A.
    Meratan, Ali Akbar
    JOURNAL OF MOLECULAR BIOLOGY, 2023, 435 (12)
  • [30] The Role of Astrocytes and Alpha-Synuclein in Parkinson's Disease: A Review
    Brash-Arias, David
    Garcia, Luis I.
    Perez-Estudillo, Cesar Antonio
    Rojas-Duran, Fausto
    Aranda-Abreu, Gonzalo Emiliano
    Herrera-Covarrubias, Deissy
    Chi-Castaneda, Donaji
    NEUROSCI, 2024, 5 (01): : 71 - 86